Zobrazeno 1 - 10
of 759
pro vyhledávání: '"R. Pond"'
Autor:
Erin Vink, Gabriella Antaya, Camille Hamula, Carla Holinaty, Jessica Minion, Gregory R. Pond, Sabryna McCrea, Lynn Dwernychuk, Holly Graham, Gordon Broderick, Mary Kinloch, Jennifer Brown Broderick
Publikováno v:
Current Oncology, Vol 31, Iss 8, Pp 4261-4269 (2024)
Of all cancers in female Canadians, the most rapidly increasing incidence is that of cervical cancer. The objective of this pilot study was to assess how HPV self-sampling might improve cervical cancer screening participation in both urban and rural
Externí odkaz:
https://doaj.org/article/029066d781d2440b9c510cb766382f26
Autor:
Oren Levine, Daryl Bainbridge, Gregory R. Pond, Marissa Slaven, Sukhbinder Dhesy-Thind, Jonathan Sussman, Ralph M. Meyer
Publikováno v:
Current Oncology, Vol 31, Iss 6, Pp 3329-3341 (2024)
Early integrated palliative care (EIPC) for patients with advanced cancers requires the involvement of family doctors (FDs) and oncologists. We compared attitudes between patients and their providers regarding the delivery of EIPC. Patients with newl
Externí odkaz:
https://doaj.org/article/7ef8fee4673e40f29536aa9604a4e6a8
Autor:
Ghulam Rehman Mohyuddin, Hira Mian, Anastasia Gayowsky, Hsien Seow, Rajshekhar Chakraborty, Gregory R. Pond, Samer Al Hadidi, Alissa Visram
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-2 (2024)
Externí odkaz:
https://doaj.org/article/f2165410681c443d857b7b0aef87436c
Publikováno v:
BMJ Oncology, Vol 3, Iss 1 (2024)
In the field of general medicine, class effects, or therapeutic interchangeability, have been declared for several families of drugs including statins, calcium channel blockers and ACE inhibitors. The existence of such class effects enables healthcar
Externí odkaz:
https://doaj.org/article/861132a319e645919ea21c894d139add
Autor:
Ricardo Fernandes, Terry L. Ng, Mashari Jemaan Alzahrani, Jacques Raphael, Phillip Blanchette, Morgan Black, Carol Stober, Gregory R. Pond, David Cella, Lisa Vandermeer, Mohammed Ibrahim, Mark Clemons
Publikováno v:
Current Oncology, Vol 30, Iss 8, Pp 7384-7397 (2023)
Background: Neither paclitaxel plus trastuzumab (P-H) nor docetaxel-cyclophosphamide plus trastuzumab (TC-H) have been prospectively compared in HER2-positive early-stage breast cancer (EBC). A randomized trial was performed to assess the feasibility
Externí odkaz:
https://doaj.org/article/c4a34249d38c4c15b7d83418937e50a6
Trainee Evaluations of Preparedness for Clinical Trials in Medical Oncology—A National Questionnaire
Publikováno v:
Current Oncology, Vol 30, Iss 8, Pp 7627-7637 (2023)
Background: A standardized approach to the education of clinical trial investigators across Canadian medical oncology (MO) subspecialty training does not exist. With training programs transitioning to competency-based medical education (CBME), studie
Externí odkaz:
https://doaj.org/article/b316f4acd6cb47a0bb36b83a03e5fa74
Autor:
Ana-Alicia Beltran-Bless, Bader Alshamsan, Mashari Jemaan Alzahrani, John Hilton, Kelly-Anne Baines, Vicky Samuel, Gregory R. Pond, Lisa Vandermeer, Mark Clemons, Gail Larocque
Publikováno v:
Breast, Vol 69, Iss , Pp 274-280 (2023)
Purpose: Follow-up care of early breast cancer (EBC) patients usually includes routinely scheduled physical examinations. While ASCO guidelines recommend a physical exam every three to six months for the first three years, little evidence supports th
Externí odkaz:
https://doaj.org/article/7311e20af77e440899563f6f9723ccab
Autor:
Christa Aubrey, Gregory R. Pond, Limor Helpman, Danielle Vicus, Laurie Elit, Marie Plante, Susie Lau, Janice S. Kwon, Alon D. Altman, Karla Willows, Tomer Feigenberg, Jeanelle Sabourin, Vanessa Samouelian, Laurence Bernard, Norah Cockburn, Nora-Beth Saunders, Sabrina Piedimonte, Ly-Ann Teo-Fortin, Soyoun Rachel Kim, Noor Sadeq, Ji-Hyun Jang, Sarah Shamiya, Gregg Nelson
Publikováno v:
Current Oncology, Vol 30, Iss 2, Pp 1977-1985 (2023)
Minimally invasive surgery for the treatment of macroscopic cervical cancer leads to worse oncologic outcomes than with open surgery. Preoperative conization may mitigate the risk of surgical approach. Our objective was to describe the oncologic outc
Externí odkaz:
https://doaj.org/article/0d3954a81af94f889a37742b30ebd835
Publikováno v:
Current Oncology, Vol 29, Iss 12, Pp 9046-9065 (2022)
Small cell lung cancer (SCLC) is an aggressive neuroendocrine carcinoma with early metastatic potential. The standard-of-care treatment has not changed in years. Recent studies report improved progression-free survival (PFS) and overall survival (OS)
Externí odkaz:
https://doaj.org/article/d1ce9d3e5fc24c4eb97ae5b568df9cce
Autor:
Craig A. Beers, Gregory R. Pond, James R. Wright, Theodoros Tsakiridis, Gordon S. Okawara, Anand Swaminath
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
PurposeFluoro-2-deoxyglucose positron-emission tomography (FDG-PET/CT) is now considered a standard investigation for the staging of new cases of stage III NSCLC. However, there is not published level 3 evidence demonstrating the impact of FDG-PET/CT
Externí odkaz:
https://doaj.org/article/8fcea20f776c4ae7ad659453e8722111